| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 97 | 711 | 1,410 | 1,875 | | Cost of Revenue | 239 | 577 | 848 | 1,077 | | | Gross Profit | (142) | 133 | 563 | 798 | | | Operating Expenses | | Research Development | 314 | 241 | 118 | 152 | | Selling General and Administrative | 1,928 | 2,367 | 2,088 | 2,176 | | Non Recurring |
-
| 236 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,384) | (2,711) | (1,643) | (1,529) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (637) | (841) | 63 | 143 | | Earnings Before Interest And Taxes | (3,286) | 406 | (2,502) | (1,276) | | Interest Expense | 21 | 19 | 27 | 16 | | Income Before Tax | (3,306) | 387 | (2,529) | (1,293) | | Income Tax Expense | (1,321) | 328 | (1,111) | (632) | | Minority Interest |
-
| 34 | (71) | (272) | | | | Net Income From Continuing Ops | (1,985) | 94 | (1,489) | (932) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,985) | 94 | (1,489) | (932) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,985) | $94 | ($1,489) | ($932) |
|
1.23% Nasdaq 0.00%
Income Statement
